Use of antidepressants and risk of colorectal cancer: A nested case-control study

Lancet Oncology

Volumn 7, Issue 4, 2006, Pages 301-308

  Xu, Wanning ^a   Tamim, Hani ^a   Shapiro, Stan ^a,b   Stang, Mary Rose ^c   Collet, Jean Paul ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Saskatchewan Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CANCER REGISTRY; CANCER RISK; CHILD; COLORECTAL CANCER; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; DRUG MEGADOSE; ENTERITIS; GENOTOXICITY; HUMAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RANDOMIZATION; CANADA; CASE CONTROL STUDY; COLORECTAL TUMOR; FEMALE; INCIDENCE; MALE; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SASKATCHEWAN; SEROTONIN UPTAKE INHIBITORS;

EID: 33645776219     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70622-2     Document Type: Article

References (53)

1. SB Patten JV Williams J Wang et al. Antidepressant pharmacoepidemiology in a general population sample J Clin Psychopharmacol 25 2005 285-287
2. ME Hemels G Koren TR Einarson Increased use of antidepressants in Canada: 1981-2000 Ann Pharmacother 36 2002 1375-1379
3. M Fisch Treatment of depression in Cancer J Natl Cancer Inst Monogr 32 2004 105-111
4. MB Keller RJ Boland Antidepressants A Tasman J Kay JA Lieberman Psychiatry 2nd edn. 2003 John Wiley and Sons Hoboken 1990-2032
5. Anon Drugs facts and comparisons 56th edn. 2002 Wolters Kluwer Company St Louis 929
6. LJ Brandes RJ Arron RP Bogdanovic et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses Cancer Res 52 1992 3796-3800
7. SO Dalton C Johansen L Mellemkjaer et al. Antidepressant medications and risk for cancer Epidemiology 11 2000 171-176
8. BL Harlow DW Cramer JA Baron et al. Psychotropic medication use and risk of epithelial ovarian cancer Cancer Epidemiol Biomarkers Prev 7 1998 697-702
9. CR Sharpe JP Collet E Belzile et al. The effects of tricyclic antidepressants on breast cancer risk Br J Cancer 86 2002 92-97
10. PG Moorman JM Grubber RC Millikan B Newman Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast Epidemiology 14 2003 307-314
11. PG Moorman A Berchuck B Calingaert et al. Antidepressant medication use (corrected) and risk of ovarian cancer Obstet Gynecol 105 2005 725-730
12. S Dublin MA Rossing SR Heckbert et al. Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications Cancer Causes Control 13 2002 35-45
13. PF Coogan- L Rosenberg JR Palmer et al. Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States) Cancer Causes Control 11 2000 839-845
14. PS Wang AM Walker MT Tsuang et al. Antidepressant use and the risk of breast cancer: A non-association J Clin Epidemiol 54 2001 728-734
15. M Cotterchio N Kreiger G Darlington A Steingart Antidepressant medication use and breast cancer risk Am J Epidemiol 151 2000 951-957
16. JP Kelly L Rosenberg JR Palmer et al. Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines Am J Epidemiol 150 1999 861-868
17. JU Rosholm LF Gram G Isacsson et al. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: A prescription database study Eur J Clin Pharmacol 52 1997 205-209
18. PJ Tutton DH Barkla Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas Br J Cancer 46 1982 260-265
19. PJ Tutton DH Barkla The influence of serotonin on the mitotic rate in the colonic crypt epithelium and in colonic adenocarcinoma in rats Clin Exp Pharmacol Physiol 5 1978 91-94
20. PJ Tutton GG Steel Influence of biogenic amines on the growth of xenografted human colorectal carcinomas Br J Cancer 40 1979 743-749
21. DH Barkla PJ Tutton Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumours J Natl Cancer Inst 67 1981 1207-1211
22. E Seretis A Gavrill N Agnantis et al. Comparative study of serotonin and bombesin in adenocarcinomas and neuroendocrine tumors of the colon Ultrastruct Pathol 25 2001 445-454
23. CT Yue YL Liu Fluoxetine increases extracellular levels of 3-methoxy-4-hydroxyphenylglycol in cultured COLO320 DM cells Cell Biochem Funct 23 2005 109-114
24. PJ Tutton DH Barkla Effect of an inhibitor of noradrenalin uptake, desispramine, on cell proliferation in the intestinal crypt epithelium Virchows Arch B Cell Pathol Incl Mol Pathol 57 1989 349-352
25. H Iishi M Tatsuta M Baba H Taniguchi Enhancement by the tricyclic antidepressant, desipramine, of experimental carcinogenesis in rat colon induced by azoxymethane Carcinogenesis 14 1993 1837-1840
26. N Van Schaik U Graf Genotoxicity evaluation of five tricyclic antidepressants in the wing somatic mutation and recombination test in Drosophila melanogaster Mutat Res 260 1991 99-104
27. N Van Schaik U Graf Structure-activity relationships of tricyclic antidepressants and related compounds in the wing somatic mutation and recombination test of Drosophila melanogaster Mutat Res 86 1993 155-163
28. H Tamim The effects of antidepressant drugs on the risk of cancer: A population-based case-control study Dissertation 2003 McGill University
29. W Downey MR Stang P Beck et al. Health databases in Saskatchewan BL Strom Pharmacoepidemiology 4th edn. 2005 John Wiley New York 295-310
30. Government of Saskatchewan Saskatchewan census population http://www.stats.gov.sk.ca/pop/census8101.pdf (accessed Jan 26, 2006)
31. Government of Saskatchewan Saskatchewan inter-provincial net migration, by age group http://www.stats.gov.sk.ca/pop/netmigrationbyage.pdf (accessed Jan 26, 2006)
32. Government of Saskatchewan http://formulary.drugplan.health.gov.sk.ca/ (accessed Feb 13, 2006)
33. C Percy V Van Holten C Muir International classification of diseases for oncology 2nd edn. 1990 World Health Organization Geneva
34. S Budavari MJ O'Neil A Smith PE Heckelman The Merck Index. An encyclopedia of chemicals, drugs, and biologicals 11th edn. 1989 Merck Rahway
35. JP Collet JF Boivin Bias and confounding in pharmacoepidemiology BL Strom Pharmacoepidemiology 3rd edn. 2000 John Wiley New-York 765-784
36. ES Paykel Continuation and maintenance therapy in depression Br Med Bull 57 2001 145-159
37. E Giovannucci Modifiable risk factors for colon cancer Gastroenterol Clin North Am 31 2002 925-943
38. T Rutledge SE Reis M Olson et al. Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: The WISE study Psychosom Med 63 2001 282-288
39. N Breslau EL Peterson LR Schultz et al. Major depression and stages of smoking. A longitudinal investigation Arch Gen Psychiatry 55 1998 161-166
40. JC Barefoot BL Heitmann MJ Helms et al. Symptoms of depression and changes in body weight from adolescence to mid-life Int J Obes Relat Metab Disord 22 1998 688-694
41. CH Kroenke GG Bennett C Fuchs et al. Depressive symptoms and prospective incidence of colorectal cancer in women Am J Epidemiol 162 2005 839-848
42. JN Poynter SB Gruber PD Higgins et al. Statins and the risk of colorectal cancer N Engl J Med 352 2005 2184-2192
43. RE Morgan LA Palinkas EL Barrett-Connor DL Wingard Plasma cholesterol and depressive symptoms in older men Lancet 341 1993 75-79
44. PHA Steegmans AW Hoes AA Bak et al. Higher prevalence of depressive symptoms in middle-aged man with low serum cholesterol levels Psychosom Med 62 2000 205-211
45. J Wardle Cholesterol and psychological well-being J Psychosom Res 39 1995 549-562
46. SO Olusi AA Fido Serum lipid concentrations in patients with major depressive disorder Biol Psychiatry 40 1996 1128-1131
47. G Borgherini S Dorz D Conforti et al. Serum cholesterol and psychological distress in hospitalized depressed patients Acta Psychiatr Scand 105 2002 149-152
48. JM Kim R Stewart IS Shin JS Yoon Vascular disease/risk and late-life depression in a Korean community population Br J Psychiatr 185 2004 102-107
49. SO Dalton EH Boesen L Ross et al. Mind and cancer: Do psychological factors cause cancer? Eur J Cancer 38 2002 1313-1323
50. SC Larsson N Orsini A Wolk Diabetes mellitus and risk of colorectal cancer: A meta-analysis J Natl Cancer Inst 97 2005 1679-1687
51. S Beliard R Valero B Vialettes Atypical neuroleptics and diabetes Diabetes Metab 29 2003 296-299
52. RG Maunder Evidence that stress contributes to inflammatory bowel disease: Evaluation, synthesis, and future directions Inflamm Bowel Dis 11 2005 600-608
53. JH Kristensen KF Ilett LP Hackett et al. Distribution and excretion of fluoxetine and norfluoxetine in human milk Br J Clin Pharmacol 48 1999 521-527